|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 14/605 | (2006.01) |
| A61K 38/00 | (2006.01) | ||
| A61K 38/17 | (2006.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61K 38/22 | (2006.01) |
| (11) | Number of the document | 4301770 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22714958.0 |
| Date of filing the European patent application | 2022-03-02 | |
| (97) | Date of publication of the European application | 2024-01-10 |
| (45) | Date of publication and mention of the grant of the patent | 2025-08-27 |
| (46) | Date of publication of the claims translation | 2025-11-10 |
| (86) | Number | PCT/US2022/018434 |
| Date | 2022-03-02 |
| (87) | Number | WO 2022/187305 |
| Date | 2022-09-09 |
| (30) | Number | Date | Country code |
| 202163155894 P | 2021-03-03 | US |
| (72) |
ABRAHAM, Milata Mary , US
BRIERE, Daniel Anthony , US
GUO, Lili , US
KEYSER, Samantha Grace Lyons , US
LEE, John , US
QU, Hongchang , US
|
| (73) |
Eli Lilly and Company ,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Ilgai veikiantys amilino receptoriaus agonistai ir jų panaudojimas |
| LONG-ACTING AMYLIN RECEPTOR AGONISTS AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2026-02-19 | 5 | 115.00 EUR |
| 2027-03-02 |